This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 4.08 points to 772.92 Wednesday. Connor Cruise's halted capital pool shell, Brassneck Capital Corp. (BC), has submitted a filing statement for its qualifying transaction, which is the acquisition of National Access Cannabis Corp. (NAC). The shell will split its shares 1.205 for 1, leaving it with 8,361,495 shares issued, then issue 107,612,568 shares to its target's shareholders.

NAC is based in Ottawa. It operates 10 marijuana consultation clinics from Halifax to Victoria. The clinics take patients who are at least 20 years old. (Those under 25 need parental consent.) A patient would provide medical documentation for his condition, whatever it may be, then consult with a doctor who would prescribe a marijuana treatment, if applicable. On its Twitter page, NAC features a patient named Kalin, who suffers from an inflammatory bowel disease called Crohn's disease. Kalin says: "Medical cannabis is doing everything and doing it better than the prescription drugs I was taking, with no side effects or long-term effects. It's amazing, I can go out and have a life again." NAC's website explains that "although there are no official guidelines for its use for specific conditions, the ACMPR [Access to Cannabis for Medical Purposes Regulations] allows medical cannabis to be recommended as treatment for almost any condition or ailment."

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS